Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations

British Journal of Ophthalmology

Volumn 88, Issue 11, 2004, Pages 1455-1459

  Mwanza, Jean Claude ^a,b   Nyamabo, L K ^b   Tylleskar T ^a   Plant, G T ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b Kinshasa University Hospital   (Congo)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOCOCCOSIS; EVOKED VISUAL RESPONSE; EYE MOVEMENT DISORDER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROOPHTHALMOLOGY; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; PAPILLEDEMA; PRIORITY JOURNAL; TOXOPLASMOSIS; VISUAL FIELD DEFECT; VISUAL SYSTEM;

ADULT; CRYPTOCOCCOSIS; EVOKED POTENTIALS, VISUAL; EYE DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OCULAR MOTILITY DISORDERS; OCULOMOTOR NERVE DISEASES; OPTIC NERVE DISEASES; TOXOPLASMOSIS; VISUAL FIELDS;

EID: 7044285870     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.044289     Document Type: Article

References (40)

1. UNAIDS. Annual report, December 2003.
2. Gongora-Rivera F, Santos-Zambrano J, Moreno-Andrade T, et al. The clinical spectrum of neurological manifestations in AIDS patients in Mexico. Arch Med Res 2000;31:393-8.
3. Perriens JH, Mussa M, Luabeya MK, et al. Neurological complications of HIV-1-seropositive internal medicine inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr 1992;5:333-40.
4. Levy RM, Bredesen DE, Rosenblum ML. Neurologic complications of HIV infection. Am Fam Physician 1990;41:517-36.
5. Gray F, Adle-Biassette H, Chretien F, et al. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20:146-55.
6. Jabs D, Quinn T. Acquired immunodeficiency syndrome. In: Repose J, Holland G, Wilhelmus K, eds. Ocular infection and immunity. St Louis: Mosby-Year Book, 1996:289-310.
7. Keane JR. Neuro-ophthalmologic signs of AIDS: 50 patients. Neurology 1991;41:841-5.
8. Jabs DA, Green WR, Fox R, et al. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989;96:1092-9.
9. Mansour AM. Neuro-ophthalmic findings in acquired immunodeficiency syndrome. J Clin Neuroophthalmol 1990;10:167-74.
10. Sadun AA, Repose JS, Madigan MC, et al. AIDS-related optic neuropathy: a histological, virological and ultrastruclural study. Graefes Arch Clin Exp Ophthalmol 1995;233:387-98.
11. Currie J. AIDS and neuro-ophthalmology. Curr Opin Ophthalmol 1995;6:34-40.
12. Friedman DI. Neuro-ophthalmic manifestations of human immunodeficiency virus infection. Neurol Clin 1991;9:55-72.
13. Woods AD, Caputo MK. Neuro-ophthalmic manifestations of AIDS. Opfom Clin 1996;5:113-52.
14. Mwanza JC, Lysebo D, Kayembe DL, et al. Visual evoked potentials in konzo, a spastic paraparesis of acute onset in Africa. Ophthalmologica 2003;217:381-6.
15. Maschke M, Kastrup O, Esser S, et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000;69:376-80.
16. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001;56:257-60.
17. Goldsmith P, Jones RE, Ozuzu GE, et al. Optic neuropathy as the presenting feature of HIV infection: recovery of vision with highly active antiretroviral therapy. Br J Ophthalmol 2000;84:551-3.
18. Larsen M, Toft PB, Bernhard P, et al. Bilateral optic neuritis in acute human immunodeficiency virus infection. Acta Ophthalmol Scand 1998;76:737-8.
19. Tenhula WN, Xu SZ, Madigan MC, et al. Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol 1992;113:14-20.
20. Madigan MC, Sadun AA, Rao NS, et al. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res 1996;18:176-84.
21. Lin XH, Kashima Y, Khan M, et al. An immunohistochemical study of TNF-alpha in optic nerves from AIDS patients. Curr Eye Res 1997;16:1064-8.
22. Kolson DL, Lavi E, Gonzalez-Scarano F. The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res 1998;50:1-47.
23. Johnston JL, Miller JD, Nath A. Ocular motor dysfunction in HIV-1-infected subjects: a quantitative oculographic analysis. Neurology 1996;46:451-7.
24. Frieaman DI, Feldon SE. Eye movement abnormalities in the AIDS dementia syndrome. Neurology 1989;39:355.
25. Merrill PT, Paige GD, Abrams RA, et al. Ocular motor abnormalities in human immunodeficiency virus infection. Ann Neurol 1991;30:130-8.
26. Castello E, Baroni N, Pallestrini E. Neurotological auditory brain stem response findings in human immunodeficiency virus-positive patients without neurologic manifestations. Ann Otol Rhinol Laryngol 1998;107:1054-00.
27. Sweeney JA, Brew BJ, Keilp JG, et al. Pursuit eye movement dysfunction in HIV-1 seropositive individuals. J Psychiatry Neurosci 1991;16:247-52.
28. Currie J, Benson E, Ramsden B, et al. Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex. Arch Neurol 1988;45:949-53.
29. Helweg-Larsen S, Jakobsen J, Boesen F, et al. Neurological complications and concomitants of AIDS. Acta Neurol Scand 1986;74:467-74.
30. Freeman WR, Lerner CW, Mines JA, et al. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 1984;97:133-42.
31. Palestine AG, Rodrigues MM, Macher AM, et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 1984;91:1092-9.
32. Engstrom JW, Lewis E, McGuire D. Cranial neuropathy and and the acquired immunodeficiency syndrome. Neurology 1991;41:374.
33. Malessa R, Agelink MW, Diener HC. Dysfunction of visual pathways in HIV-1 infection. J Neurol Sci 1995;130:82-7.
34. Pierelli F, Soldati G, Zambardi P, et al. Electrophysiological study (VEP, BAEP) in HIV-1 seropositive potients with and without AIDS. Acto Neurol Belg 1993;93:78-87.
35. Iragui VJ, Kalmijn J, Plummer DJ, et al. Pattern electroretinograms and visual evoked potentials in HIV infection: evidence of asymptomatic retinal and postretinal impairment in the absence of infectious retinopathy. Neurology 1996;47:1452-6.
36. Famarier G, Somma-Mauvais H. Multimodal evoked potentials in HIV infected patients. Electroencephalogr Clin Neurophysiol 1990;41:355-69.
37. Smith T, Jakobsen J, Gaub J, et al. Clinical and electrophysiological studies of human immunodeficiency virus-seropositive men without AIDS. Ann Neurol 1988;23:295-7.
38. Sample PA, Plummer DJ, Mueller AJ, et al. Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol 1999;117:755-00.
39. Plummer DJ, Bartsch DU, Azen SP, et al. Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients. Am J Ophmalmol 2001;131:210-22.
40. Tran Dinh YR, Mamo H, Cervoni J, et al. Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J Nucl Med 1990;31:1601-7.